BCH: 2Q20 Earnings Should Be the Bottom Quarter
Yesterday analyst meeting came out with a neutral tone. We expect 2Q20 earnings to be the bottom quarter, given full quarter impact from COVID-19...
418 Views
BCH: Positive Sentiment from New Rate Adjustment for SSO Patients
Yesterday's analyst meeting came out with a positive tone. We maintain our BUY rating with a target price of Bt21.0 based on DCF on the back of...
487 Views
BCH: Private Chain Hospital with High Sustainable Growth
We initiate coverage on BCH with a BUY rating, based on a target price of Bt21, which is derived from a DCF methodology (WACC 6.8% and terminal...
648 Views
VIBHA: Large Hospital Chain at the Cheapest Price
We initiate coverage of VIBHA with a BUY rating, based on a target price of Bt3.0 derived from 38xPE’19E, which is equal to the stock’s five-year...
629 Views
MEGA: Supplement Maker Spreads Healthy Message in Booming Region
We initiate coverage on MEGA with a BUY rating and based on a target price of Bt43, which is derived from the DCF methodology (WACC 12.5% and...
511 Views